Viewing Study NCT03458260


Ignite Creation Date: 2025-12-25 @ 2:10 AM
Ignite Modification Date: 2026-01-06 @ 12:29 PM
Study NCT ID: NCT03458260
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-10-09
First Post: 2018-02-26
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Pixantrone in CD20+ Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma
Sponsor: The Lymphoma Academic Research Organisation
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Aggressive Non-Hodgkin Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Diffuse Large B-Cell Lymphoma (DLBCL) View
None relapsed or refractory View